Jiangsu Nanfang Medical Co., Ltd.

¥7.74As of Sun 8 Nov 2026, 12:00 UTC
SSE:603880Healthcare
Country China
PE (Fwd) •••
TSR 9Y CAGR (3.78%)
Div yield —
ROE (50.76%)
Medical Instruments & Supplies
Beta (5Y) 0.53
PE TTM —
TSR TTM 16.74%
Mkt cap ¥2.237B
ROIC (15.47%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥8.24
6.43%
(89.70%)
Hold 4|6|4|11|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.10
0.10
0.09
0.09
23.78%
17.67%
5.83%
(2.28%)
Revenue¥M
102.3
103.6
104.4
105.4
6.08%
4.82%
4.50%
0.41%
Peers (US$335.4M)
Cap (US$)
PE
319.8M
222.1x
350.7M
4.212x
Capital
TTM
5Y
10Y
Leveragex
0.209
0.440
0.283
EBIT/Intx
1.457
0.433
0.337
Own earn%
39.39
32.12
41.02
Sh yield%
37.53
20.85
20.34
Owners
Insiders/Inst%
7.50
58.94
Short interest%
4.94
SBC / revenue%
4.48
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
11
Op margin range%
7–13
$1 testx
0.0
Incr. ROIC%
22